Rutella S, Rumi C, Lucia M B, Barberi T, Puggioni P L, Lai M, Romano A, Cauda R, Leone G
Department of Hematology, Catholic University, Rome, Italy.
Cytometry. 1999 Jun 15;38(3):95-101.
We evaluated phenotype and apoptotic status of normal CD4+CD69+ and CD8+CD69+ peripheral blood T-lymphocytes after short-term challenge with escalating concentrations of phytohemagglutinin (PHA). The frequency of CD69-coexpressing CD4+ and CD8+ T-cells and CD69 staining intensity increased following T-cell mitogenic stimulation; these changes were proportional to PHA concentration in culture medium. A considerable fraction of lymphocytes underwent blast transformation, displaying increased forward and side scatter signals. Interestingly enough, PHA-responsive T-cells exhibited a predominantly CD25negCD38negTCRalphabetapos phenotype; APO-1/Fas antigen (CD95) could be detected on a minority of activated CD69+ T-cells. A considerable proportion of CD69+ lymphocytes expressed intracellular perforin; in addition, an average 16+/-6% CD69+ T-lymphocytes were apoptotic after 4 h of stimulation, as evaluated by 7-amino-actinomycin-D staining and by annexin-V binding. CD69+ activated lymphocytes comprise phenotypically heterogeneous cell subpopulations potentially devoted to diverse immunological functions, i.e., proliferation, apoptosis, or cell cytotoxicity; moreover, our findings indicate that CD69 expression is proportional to the intensity of the activating stimulus and that the capacity to upregulate CD69 antigen following short-term mitogenic challenge may be restricted to unactivated CD38negCD25negTCRalphabetapos T-lymphocytes.
我们评估了在以递增浓度的植物血凝素(PHA)进行短期刺激后,正常CD4⁺CD69⁺和CD8⁺CD69⁺外周血T淋巴细胞的表型和凋亡状态。T细胞有丝分裂原刺激后,共表达CD69的CD4⁺和CD8⁺T细胞的频率以及CD69染色强度增加;这些变化与培养基中PHA的浓度成正比。相当一部分淋巴细胞发生了母细胞转化,表现为前向和侧向散射信号增加。有趣的是,对PHA有反应的T细胞主要表现为CD25⁻CD38⁻TCRαβ⁺表型;在少数活化的CD69⁺T细胞上可检测到APO-1/Fas抗原(CD95)。相当比例的CD69⁺淋巴细胞表达细胞内穿孔素;此外,通过7-氨基放线菌素-D染色和膜联蛋白-V结合评估,刺激4小时后,平均16±6%的CD69⁺T淋巴细胞发生凋亡。CD69⁺活化淋巴细胞包含表型异质性的细胞亚群,可能具有多种免疫功能,即增殖、凋亡或细胞毒性;此外,我们的研究结果表明,CD69的表达与激活刺激的强度成正比,并且短期有丝分裂原刺激后上调CD69抗原的能力可能仅限于未活化的CD38⁻CD25⁻TCRαβ⁺T淋巴细胞。